Citius Pharmaceuticals, Inc.
NASDAQ:CTXR
0.5481 (USD) • At close September 19, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -32.543 | -33.641 | -23.054 | -17.548 | -15.562 | -12.537 | -10.385 | -8.296 | -2.902 | -1.272 | -0.031 | -0.022 | -0.026 |
| Afschrijvingen & Amortisatie
| 0.194 | 0.18 | 0.165 | 0.152 | 0.001 | 0.002 | 0.003 | 0.001 | 0 | 0 | 0 | 0 | 0 |
| Uitgestelde Inkomstenbelasting
| 0.576 | 0.576 | -0.167 | 0 | 0 | -0.45 | 0 | 0.844 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 6.617 | 3.906 | 1.455 | 0.803 | 0.716 | 0.78 | 0.987 | 0.732 | 0.486 | 0.47 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -4.006 | 0.24 | -2.717 | -0.867 | 2.196 | 0.51 | 0.116 | 0.668 | 0.363 | 0.165 | 0.011 | 0.002 | 0.006 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0.818 | -0.818 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | -0.818 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 1.762 | -0.112 | -0.579 | -0.857 | 1.14 | 0.971 | -0.307 | 0.105 | 0.453 | 0 | 0.011 | -0.001 | 0.001 |
| Overig Werkkapitaal
| -5.768 | 0.351 | -2.138 | -0.01 | 1.056 | -0.461 | 0.422 | 0.563 | -0.09 | 0.165 | -0.001 | 0.003 | 0.005 |
| Overige Niet-Contante Posten
| 0.102 | 0.378 | 0.068 | 0.529 | 0.212 | 0.377 | 1.312 | 0.15 | -0.332 | -0.068 | 0.103 | 0 | -0.026 |
| Kasstroom uit Operationele Activiteiten
| -29.06 | -28.361 | -24.25 | -16.931 | -12.438 | -11.318 | -7.971 | -5.9 | -2.385 | -0.705 | -0.021 | -0.02 | -0.021 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | 0 | -40.007 | -0.002 | 0 | 0 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.256 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | -0.04 | 0 | 0 | 0 | 0 | 0.256 | 0 | 0 | 0 | -0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0 | 0 | -40.007 | -0.002 | 0 | 0 | -0.002 | 0.256 | 0 | 0 | 0 | -0 | 0 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| 0 | 0 | -0.173 | -0.165 | 0 | 0 | -4.21 | -0.6 | 0 | 0 | -0.03 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 13.798 | 0 | 89.431 | 15.577 | 11.124 | 16.173 | 6.673 | 5.428 | 1.509 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0.031 | 0 | 31.213 | 7.486 | 0.023 | 1.125 | 4.21 | 0.435 | 1.509 | 2.256 | 0.051 | 0.02 | 0.018 |
| Kasstroom uit Financieringsactiviteiten
| 13.829 | 0 | 120.471 | 22.898 | 11.148 | 17.298 | 10.883 | 5.263 | 1.509 | 2.256 | 0.02 | 0.02 | 0.018 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -15.231 | -28.361 | 56.213 | 5.966 | -1.29 | 5.98 | 2.91 | -0.382 | -0.876 | 1.551 | 0.054 | -0 | -0.002 |
| Kaspositie aan het Einde van de Periode
| 26.481 | 41.712 | 70.073 | 13.86 | 7.894 | 9.184 | 3.204 | 0.294 | 0.676 | 1.605 | 0.054 | 0 | 0 |